Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 468,615 | 78,385 | 81,879 |
| Receivables | 91,992 | 58,921 | 43,038 |
| Inventories | 25,164 | 20,318 | 11,501 |
| Other current assets | 20,206 | 10,747 | 18,058 |
| TOTAL | $605,977 | $168,370 | $154,476 |
| Non-Current Assets | |||
| PPE Net | 31,714 | 19,175 | 16,713 |
| Intangibles | 0 | 263,499 | 0 |
| Other Non-Current Assets | 358,577 | 40,990 | 94,983 |
| TOTAL | $390,291 | $323,664 | $111,696 |
| Total Assets | $1,000,390 | $492,034 | $269,719 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 12,528 | 1,253 | 640 |
| Accounts payable and accrued liabilities | 92,310 | 55,589 | 54,284 |
| Other current liabilities | 79,772 | 89,937 | 41,616 |
| TOTAL | $218,303 | $170,423 | $109,669 |
| Non-Current Liabilities | |||
| Long Term Debt | 364,036 | 6,564 | 5,454 |
| Other Non-Current Liabilities | 31,641 | 36,696 | 50,559 |
| TOTAL | $407,237 | $55,150 | $61,114 |
| Total Liabilities | $625,539 | $225,573 | $170,782 |
| Shareholders' Equity | |||
| Common Shares | 393,693 | 387,454 | 296,501 |
| Retained earnings | -140,491 | -154,019 | -175,179 |
| Other shareholders' equity | 104,664 | 78,105 | 19,358 |
| TOTAL | $374,850 | $266,461 | $98,936 |
| Total Liabilities And Equity | $1,000,389 | $492,034 | $269,718 |